Company intelligence / Profile preview

Kingworld Medicines Group

Shenzhen, Guangdong, China

Ownership: Private
Employees: ~927
Development stage: Other

Overview

Kingworld Medicines Group is an established pharmaceutical and healthcare product distributor with strong sales in China, Hong Kong, and international markets. Its portfolio includes well-known OTC brands for respiratory, digestive, cardiovascular health as well as medical devices. The company has expanded into new geographies through acquisitions such as Innopharm S.A., France. It does not conduct clinical trials or develop novel therapeutics but focuses on marketing, distribution, and brand management of existing products.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularNeurology
Modalities: Small moleculeDevice
Industry: Non-Academic Healthcare

Partnerships

Sinopharm (marketing/distribution alliance in China)

Beyond the preview

Go deeper on Kingworld Medicines Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kingworld Medicines Group.

Explore the full profile